PROS1 and cancer: Specific groups of TFs that are abnormally expressed in many cancers have gained increased attention, such as steroid receptors (oestrogen receptors41 and androgen receptors42), resident nuclear proteins (c-JUN43), and latent cytoplasmic factors (STATs44 and NF-κB45).